[HTML][HTML] Donor dendritic cell–derived exosomes promote allograft-targeting immune response

Q Liu, DM Rojas-Canales, SJ Divito… - The Journal of …, 2016 - Am Soc Clin Investig
Q Liu, DM Rojas-Canales, SJ Divito, WJ Shufesky, DB Stolz, G Erdos, MLG Sullivan…
The Journal of clinical investigation, 2016Am Soc Clin Investig
The immune response against transplanted allografts is one of the most potent reactions
mounted by the immune system. The acute rejection response has been attributed to donor
dendritic cells (DCs), which migrate to recipient lymphoid tissues and directly activate
alloreactive T cells against donor MHC molecules. Here, using a murine heart transplant
model, we determined that only a small number of donor DCs reach lymphoid tissues and
investigated how this limited population of donor DCs efficiently initiates the alloreactive T …
The immune response against transplanted allografts is one of the most potent reactions mounted by the immune system. The acute rejection response has been attributed to donor dendritic cells (DCs), which migrate to recipient lymphoid tissues and directly activate alloreactive T cells against donor MHC molecules. Here, using a murine heart transplant model, we determined that only a small number of donor DCs reach lymphoid tissues and investigated how this limited population of donor DCs efficiently initiates the alloreactive T cell response that causes acute rejection. In our mouse model, efficient passage of donor MHC molecules to recipient conventional DCs (cDCs) was dependent on the transfer of extracellular vesicles (EVs) from donor DCs that migrated from the graft to lymphoid tissues. These EVs shared characteristics with exosomes and were internalized or remained attached to the recipient cDCs. Recipient cDCs that acquired exosomes became activated and triggered full activation of alloreactive T cells. Depletion of recipient cDCs after cardiac transplantation drastically decreased presentation of donor MHC molecules to directly alloreactive T cells and delayed graft rejection in mice. These findings support a key role for transfer of donor EVs in the generation of allograft-targeting immune responses and suggest that interrupting this process has potential to dampen the immune response to allografts.
The Journal of Clinical Investigation